• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Veeva Systems honored by Forbes and Deloitte

Veeva Systems honored by Forbes and Deloitte

March 23, 2016
CenterWatch Staff

Veeva Systems, a provider of industry cloud solutions for life sciences, has received several prestigious industry awards for its innovation, product excellence and customer success.

“It’s an honor to be recognized for our innovation in industry cloud, exceptional company culture, and dedication to customer success,” said Peter Gassner, Veeva founder and CEO. "We continue to grow quickly, fueled by focusing on the customer and delivering mission-critical products that keep our customers a step ahead.”

Veeva delivers industry cloud software solutions to help life sciences companies achieve their most pressing strategic objectives—bringing drugs to market faster and more efficiently, better market and sell, and improve compliance with government regulations. 

Veeva was listed in Forbes magazine as a best software company to work for in 2015. The ranking was based on analysis of third-party ratings of global software companies featured in Software Magazine’s Software 500 list.

With revenue growth of 621% from 2011 to 2014, Veeva was ranked 139 in Deloitte’s 2015 Technology Fast 500 survey of North America’s fastest-growing technology, media, telecommunications, life sciences, and energy technology companies. Veeva also recently announced its fiscal 2016 results, demonstrating again a unique combination of high growth and profitability.

Veeva OpenData was recognized as one of the most innovative products for its new approach to life sciences customer reference data by PM360, a leading life sciences industry publication. Available in 35 countries and counting, companies can rely on a single vendor for all major markets with Veeva OpenData. Priced by the record—with a defined-per country maximum—organizations now have a fair and predictable cost of ownership, which is a marked change from the current practice of being charged multiple times to use the same data across teams and departments.

Veeva CRM Suggestions was named as a pharmaceutical marketing innovation to watch by MedAdNews for its game-changing capability to engage customers. Veeva CRM Suggestions leverages the power of data science to deliver a better, more coordinated customer experience by offering recommendations to sales reps on the best action and right channel for the next customer interaction.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing